Currently, the govt directly caps prices of 348 formulations at the average price of all medicines in a particular segment with at least 1% market share
Among the companies likely to sign deals with Gilead are Cadila, Hetero, Strides Arcolab and Mylan, while Cipla is expected to earn active pharmaceutical ingredient rights.
It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues
The idea is to keep a close watch on real-time price movements, the maximum retail price of medicines and their availability.
Twenty-year-old Ripal Prajapati had to settle for mailing a 'rakhi' to her god-brother this time around.
.jpg)
The creation of the Amul brand and its famous mascot gave a rural revolution a durable competitive edge.
The Ministry of Science and Technology has approached about a dozen well-known scientists from across the world in an effort to bring them back to various departments under the ministry, said Jitendra Singh, minister of state (independent charge) for science and technology.
Ministerial consultations on, with recognition of the potential, and the need to not classify it under the same rules as for pharmaceuticals.
Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.
Sun Pharma to retain these in most markets; US could be the exception, where the Ranbaxy name has taken a hit.
Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.
Sun-Ranbaxy are keen to complete the merger process.
Car makers have started hiring from Gujarat's industrial training institutes (ITIs) for their factories across the country.
.jpg)
In a letter to health minister Harsh Vardhan, the Indian Pharmaceutical Alliance, an industry body representing leading pharma companies, including Sun Pharma, Lupin, Dr Reddy's Labs, Cadila Health and Glenmark, stressed the need for an out-of-court settlement with health activists fighting for the rights of clinical trial participants.
The Drug (Prices Control) Order implemented in May last year brought into its purview 652 packs of 348 formulations.
The company did not respond to specific queries on the project's expansion.
Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.
Experts say despite it being a global deal, the transaction will have to undergo CCI scrutiny because of the scale of operations.
On Tuesday, Novartis agreed to buy GSK's oncology products business for $14.5 billion, while selling its vaccines business, excluding flu, to GSK for $7.1 billion.
ICAI has also imposed a fine of Rs 5 lakh on each of the three accused in Satyam case.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances